Story

Verbio Shares Surge After FY26 EBITDA Surpasses Upgraded Guidance

ENTHMSVIIDZHZH-TWJAKOHI
Aug 4, 20261 min read
Verbio Shares Surge After FY26 EBITDA Surpasses Upgraded Guidance
Text size
Background

Shares of Verbio Vereinigte Bioenergie AG (VBKG) surged on Tuesday after the company announced preliminary full-year earnings that beat its own recently upgraded financial targets. The stock climbed 7.7% to €29.52 in response to the positive operational and balance sheet news.

Earnings Beat Upgraded Forecast

Verbio disclosed late Monday that it expects to report earnings before interest, taxes, depreciation, and amortization (EBITDA) of approximately €192 million for the 2025/2026 fiscal year. This figure surpasses the company's own guidance range of €160 million to €180 million, which had been raised in late May 2026.

According to the company's announcement, the stronger-than-expected performance was driven by two main factors:

  • Improved CO2 efficiency across its portfolio of biofuels.
  • Higher sales prices than management had previously modeled.

Balance Sheet Strengthens

Sample IUX Markets – In-articleAd

Adding to the positive results, Verbio reported a significant improvement in its financial position. The company's net financial debt stood at approximately €92 million as of June 30, 2026.

This represents a decrease of about 45% from the previous year, signaling stronger-than-anticipated cash generation. The reduction in leverage helps to alleviate investor concerns that had previously weighed on the stock.

Market Context

The stock's move was supported by a broadly positive market environment. Germany's DAX 40 index had already started the month on a strong footing, while a risk-on tone in U.S. markets provided a constructive backdrop for equities.

Verbio shares opened at their session high of €29.925. While the stock remains well below its 52-week high of €47.26, the earnings beat marks a significant recovery from its 52-week low of €9.40.

Read next

More on Stocks
Back to latest news

LATEST